Hayashi et al. showed that HIF1a overactivation leads to a MDS-like phenotype in a mouse transgenic model and that HIF1a activation is essential for HSPC expansion in a MLL-PTD mutant mouse model that presents with MDS-associated features (Hayashi et al., 2018). The gene discussed is KMT2A; the disease is myelodysplastic syndrome.